10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 71,817 | 42,905 | 71,905 | 75,289 | 61,207 |
| Cost of Goods | 14,411 | 10,052 | 15,108 | 16,582 | 15,480 |
| Gross Profit | 57,406 | 32,853 | 56,797 | 58,707 | 45,727 |
| Operating Expenses | 123,072 | 72,325 | 76,789 | 67,369 | 55,303 |
| Operating Income | -65,255 | -39,420 | -19,884 | -8,080 | -9,096 |
| Interest Expense | 397 | 306 | 662 | 992 | 708 |
| Other Income | 389 | -19 | -299 | 2,046 | 209 |
| Pre-tax Income | -65,263 | -39,745 | -20,845 | -7,026 | -9,595 |
| Income Tax | 585 | 422 | 298 | 108 | 8 |
| Net Income Continuous | -65,848 | -40,167 | -21,143 | -7,134 | -9,603 |
| Net Income | $-65,848 | $-40,167 | $-21,143 | $-7,134 | $-9,603 |
| EPS Basic Total Ops | -0.65 | -0.41 | -0.22 | -0.07 | -0.33 |
| EPS Basic Continuous Ops | -0.65 | -0.41 | -0.22 | -0.07 | -0.33 |
| EPS Diluted Total Ops | -0.65 | -0.41 | -0.22 | -0.07 | -0.33 |
| EPS Diluted Continuous Ops | -0.65 | -0.41 | -0.22 | -0.07 | -0.33 |
| EBITDA(a) | $-60,378 | $-34,952 | $-15,624 | $-5,235 | $-7,055 |